Introduction
Extragonadal germ cell tumours (GCTs) are rare tumours, accounting for 1-6% of all GCT cases. [1] [2] [3] [4] [5] Extragonadal GCTs are thought to arise from germ cell precursors that remain along paths of embryonic migration and form tumours in the sacrococcygeal region, retroperitoneum, mediastinum, or other sites. 4 Although their morphological appearance is analogous to those in the gonads, the frequencies of GCT types and the patient distribution are different. The most common extragonadal GCT location in adults is the mediastinum, whereas the sacrococcygeal region and central nervous system are more common sites in children. [6] [7] [8] [9] [10] The behaviour is dependent on the combination of patient age, histology type, anatomical site, and clinical stage. 4 In some series, paediatric sacrococcygeal teratoma has presented most often in neonates 11, 12 ; however, in other studies, the mean age at surgery was higher. 13, 14 Benign behaviour is observed in most cases, although metastatic disease has been reported in a fraction of cases. The presence of immature elements in neonatal teratoma is not associated with malignant behaviour, but the presence of a non-teratomatous component (yolk sac tumour and/or embryonal carcinoma) is considered to be evidence of malignant potential and an indication for three-agent cisplatin-based chemotherapy, 15, 16 although patients with a-fetoprotein and b-human chorionic gonadotropin measurements that return to normal following surgery have been followed without chemotherapy ('watch and wait' approach) by some groups. 12, 13, 17 In the absence of non-teratomatous elements, local recurrence may occur, but up to 100% long-term survival has been described for patients with sacrococcygeal teratomas, even in the presence of immature teratoma. 18 Very rarely, sacrococcygeal teratoma recurs as yolk sac tumour, but this may represent inadequate histological sampling of the primary tumour. 19, 20 Sacrococcygeal tumour with a yolk sac tumour component has, even when metastatic, a relatively good prognosis with chemotherapy. 12, 17 Adult sacrococcygeal teratoma is very rare, with fewer data regarding prognosis, but the surgical treatment of adult sacrococcygeal teratoma has recently been discussed. 21 Metastasis was observed in three patients in a series of 26 cases (12%), exclusively in women. 21 Associated somatic-type malignancies are associated with a poor prognosis. 21, 22 Somatic-type carcinoma includes adenocarcinoma, adenosquamous carcinoma, and low-grade neuroendocrine carcinoma. 21 The isochromosome 12p [i(12p)] abnormality is typical of postpubertal testicular GCT, but is lacking in germ cell lesions with expected benign behaviour, such as paediatric testicular teratoma and ovarian mature cystic teratoma. Malignant GCTs in postpubertal patients, regardless of location, often have i (12p). [23] [24] [25] [26] [27] [28] However, the same genetic abnormality is extremely rare in paediatric cases, even those with yolk sac tumour. 14, 23, 29 Instead, the genetic alterations in malignant GCTs of prepubertal patients are frequently gains of chromosomes 1q, 3 or 20q and loss of chromosomes 1p, 4q or 6q. [30] [31] [32] Sacrococcygeal teratoma is the most common GCT of neonates, and rarely occurs in adults, 18, 22, 33, 34 but studies of their i(12p) status are extremely limited, except for one recent study. 18 We investigated the i (12p) status of a large number of primary sacrococcygeal teratomas in both children and adults, including cases with malignant GCT elements (primitive neuroectodermal tumour and yolk sac tumour).
Materials and methods
A computer-based text search of the surgical pathology files of Indiana University was conducted for 'sacrococcygeal' and 'teratoma' from 1990 to 2014, and we identified all specimens with paraffin blocks permitting the investigation of chromosomal 12p abnormalities by fluorescence in-situ hybridization (FISH). These included four specimens from adult patients and 50 specimens from 48 paediatric patients. Clinical information including patient sex, age, duration of available follow-up and patient status at last follow-up was obtained. All haematoxylin and eosin-stained sections of the tumours were reviewed by two pathologists (C.K. and L.C.) to confirm the diagnosis of teratoma and evaluate the following: histological grade of teratoma, using the same grading system as that used for ovarian teratomas, and the presence of malignant GCT. 35, 36 FISH testing was performed as previously described. 37 The slides were deparaffinized with two 15-min washes with xylene, followed by two 10-min washes with absolute ethanol. The slides were then air-dried in a fume hood. The slides were treated in 0.1 mM citric acid (pH 6.0; Zymed, Carlsbad, CA, USA) at 95°C for 10 min, rinsed in distilled water for 3 min, and washed with 2 9 SSC for 5 min. Digestion of the tissue was performed by applying 0.4 ml of pepsin (5 mg/ml in 0.01 M HCl in 0.9% NaCl) (Sigma, St Louis, MO, USA) at 37°C for 40 min. The slides were rinsed with distilled water for 3 min, washed again with 2 9 SSC for 5 min, and then airdried. Dual-colour FISH was performed by using a mixture of Spectrum Orange-labelled centromeric alpha satellite DNA probe (CEP12; Vysis, Downers Grove, IL, USA) and green-labelled RP11-267D19 5-fluorescein (12p11.21) DNA probes for chromosome 12p (Empire Genomics, Buffalo, NY, USA). The probes were diluted with tDenHyb2 (Insitus, Albuquerque, NM, USA) in ratios of 1:50 and 1:20, respectively. Five-microlitre aliquots of diluted probes were added to the slide in the reduced light condition, and slides were then covered with a coverslip and sealed with rubber cement. Denaturation was achieved by incubating the slides at 75°C for 10 min in a humidified box, and slides were then hybridized at 37°C overnight. The coverslips were removed, and the slides were washed extensively twice with 45°C prewarmed 0.1 9 SSC and 1.5 mol/l urea, for 20 min for each, and then washed with 2 9 SSC for 20 min and 2 9 SSC and 0.1% NP40 for 10 min at 45°C. The slides were further washed with room temperature 2 9 SSC for 5 min. The slides were air-dried and counterstained with 10 ll of 4 0 ,6-diamidino-2-phenylindole (DAPI Antifade; Insitus). The slides were covered and sealed with nail polish. The slides were examined under a Zeiss Axioplan 2 microscope with the following filters: SP-100 DAPI, fluorescein isothiocyanate MF-101 for Spectrum Green (12p), and Gold 31003 for Spectrum Orange (CEP12), from Chroma (Brattleboro, VT, USA). The images were acquired with a CCD, camera and analysed with ISIS software (MetaSystems, Belmont, MA, USA). Five sequential focus stacks with 0.3-lm intervals were acquired and then integrated into a single image in order to reduce thickness-related artefacts. From each tumour section, 100 nuclei were scored for signals from CEP12 (red) and 12p (green) under the fluorescence microscope with 91000 magnification, and the ratio between green and red signals was subsequently calculated. We analysed the spatial distribution of the green and red signals to detect the specific patterns of signal aggregation consistent with i(12p), as previously reported. 38 The quantitative criteria used to determine 12p overrepresentation have been described previously. 38 A classical seminoma specimen was used as a positive control for FISH analyses. Lymphocyte and stromal nuclei from the same tumour were used as normal controls for each tumour. In addition, we analysed six cases of skin punch biopsies from patients without a history of GCTs as negative controls.
Results
A total of 50 cases from 48 neonates, infants and children (two recurrent cases from two different patients) were identified. Thirty-four cases were from female patients and 14 from male patients (female/ male ratio of 2.4:1). Patient age ranged from 0 days to 8 years (median, 2 weeks). Follow-up information was available for 30 patients (range, 4-254 months; mean, 8.9 years), and all were alive with no evidence of disease, with the exception of one who was alive with disease status unknown.
Among the 48 paediatric patients, there were 44 teratomas and four tumours consisting of teratoma and yolk sac tumour (one of which also had primitive neuroectodermal tumour). The teratomas included 37 mature teratomas and 11 immature teratomas (four grade 1, two grade 2, and five grade 3). The 44 teratomas lacking a yolk sac tumour component were all negative for i(12p) (Figure 1 ). The four tumours with a yolk sac tumour component were all positive for i(12p) (Figure 2 ). The i(12p) abnormalities in all of these cases involved both the yolk sac tumour and teratoma. Not only the yolk sac tumour component had i12p, but also the associated teratoma that was morphologically indistinguishable from the teratomas without yolk sac tumour elements (Figures 1 and 2) .
A total of four adult cases from three females and one male were identified (female/male ratio of 3:1). Patient age ranged from 22 to 50 years (median, 35 years). Follow-up information was available for two patients, and both were alive with no evidence of disease at 82 and 180 months, respectively. None of these patients had a documented history of teratoma in childhood, and all cases lacked non-teratomatous GCT components, immature elements, and i(12p).
Follow-up information was therefore available for 32 patients. Two patients with teratoma had recurrence, but were alive with no evidence of disease after long-term follow-up. One patient with teratoma and yolk sac tumour had recurrence 7 months after resection. The other patients were alive with no evidence of disease at last follow-up. A detailed clinicopathological summary of all 54 cases, including their i(12p) status, is provided in Tables 1 and 2 .
Discussion
Sacrococcygeal teratomas occurring in adults are rare, and there have been limited studies on the i (12p) status of sacrococcygeal teratomas, including those with malignant GCT elements. We therefore investigated the i(12p) status of a large series of both prepubertal and postpubertal sacrococcygeal teratomas, some including yolk sac tumour and primitive neuroectodermal tumour, and correlated the findings with available long-term clinical follow-up data.
The majority (88%) of our sacrococcygeal teratomas occurred in infants (<1 year), with a female predominance (female/male ratio of 2.4:1, or 71% among the paediatric cases). These findings are similar to those obtained with large US, 12 UK 17 and Japanese 19 series of paediatric sacrococcygeal GCT cases, in which 74% (of 126 patients), 80% (of 51 patients) and 75% (of 289 patients) were girls. There were 35 mature teratomas (lacking a yolk sac tumour component, 73%), nine immature teratomas (lacking another component, 19%), and four teratomas with a yolk sac tumour component (8%). These findings are similar to those reported for the largest of these series, i.e. Yoshida et al.
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(67% mature teratoma, 16% immature teratoma, and 17% with yolk sac tumour).
All four paediatric cases with yolk sac tumour (including one that also had a primitive neuroectodermal tumour component) had i(12p). The other 44 paediatric cases (including 35 mature teratomas and nine immature teratomas) lacked i(12p). Three of the 30 paediatric cases with follow-up (10%) had recurrence, a percentage very similar to the 8.7% reported by Yoshida et al.
All four adult cases were negative for i(12p), and neither of the two patients with follow-up had recurrence. As a whole, regardless of patient age, the presence of malignant GCT components, or i(12p) status, all patients except for one were alive without evidence of disease at the time of last follow-up (mean, 9.4 years).
The occurrence of teratoma in the sacrococcygeal region is not well understood, but may be related to the presence of stem cells. Evidence for this includes the expression of the stem cell markers NANOG, OCT4, SSEA-4 and nestin in these tumours, and the high risk of recurrence if the coccyx (thought to harbour associated stem cells) is not removed along with the tumour. 39 These tumours have been believed to arise from the embryonic tail bud, 39 but the presence of foregut-derived structures, such as respiratory epithelium, has been cited as arguing against this interpretation. 40 Sacrococcygeal teratomas most commonly occur in neonates and infants, and studies have consistently shown a female predominance. 12, 15, 17 The reason for the female predominance has not been determined, but might result from later sex-specific differentiation of the caudal mesenchymal tissue, including the vertebral column and the pelvic skeleton, in the embryo. 39 Occasional examples of these tumours have been familial, with known or suspected mutations, including patients with Currarino syndrome, thought to involve the HLXB9 gene, 41 or with other genetic associations, such as partial trisomy 3q with a Cornelia de Lange syndrome-like phenotype. 42 Most of the patients, however, do not have a known genetic abnormality.
The frequency of a malignant component within a sacrococcygeal teratoma is related to patient age, with 1.5% of tumours from newborns containing a malignant component, as compared with nearly 40% of tumours from children aged >1 year. 20 It has been suggested that yolk sac tumour may occur in sacrococcygeal teratoma as a form of tumour progression. 11 This seems to be true for the wide variety of somatic tumours that may arise in sacrococcygeal GCTs, including recently reported paediatric cases with sarcoma, 43 nephroblastic elements, 44 peripheral primitive neuroectodermal tumour, 41 malignant ependymoma component, 45 neuroblastoma, 46 and malignant steroidogenic tumour, 47 and adult cases with neuroendocrine carcinoma, 48 adenocarcinoma, 49 and intestinal-type mucinous neoplasm that recurred as disseminated intraperitoneal disease with pseudomyxoma peritonei. 50 The pathogenesis of teratomas depends on the clinical setting, including patient sex, age, and anatomical location. In addition to the well-known difference in behaviour between adult testicular and ovarian teratoma, a molecular difference has recently been demonstrated immunohistochemically. IMP3, an oncofetal protein that is expressed in several malignant neoplasms, is consistently expressed in testicular teratoma, but is absent in ovarian teratoma.
51 IMP3 is also expressed in a subset of prepubertal testicular teratomas, but its association with prognosis in this group is uncertain. 52 Testicular teratomas may be behaviourally and pathogenetically separated into two broad groups: prepubertal teratomas with typically benign behaviour, and postpubertal teratomas that are typically components of malignant GCTs. The prepubertal teratomas lack i(12p) abnormalities, and are therefore thought to arise from germ cells that are cytogenetically normal, at least in terms of 12p amplification. 14, 53 The i(12p) abnormality or other 12p amplification is a nearly constant finding in adult testicular GCTs, including pure teratoma 53 ; however, occasional benign postpubertal testicular teratomas lacking 12p amplification occur. 54 Ovarian teratomas without and with non-teratomatous elements also appear to represent two pathogenetically distinct categories. 37 Ovarian teratomas lack i(12p) abnormalities, even if immature teratoma is present, unless a non-teratomatous germ cell component is present. 14, 37 Ovarian teratoma with associated yolk sac tumour and/or embryonal carcinoma frequently contains i(12p) in both the teratoma and non-teratomatous components. 37 It seems reasonable to speculate that sacrococcygeal teratomas may similarly be divided into two pathogenetically distinct categories, but few data concerning i(12p) status were previously available. On classic cytogenetic analysis, no chromosome 12 abnormalities were noted in 18 paediatric sacrococcygeal teratomas, including cases with immature teratoma but no non-teratomatous component (three cases) and cases with non-teratomatous components (six cases).
14 A series of 14 paediatric and five adult sacrococcygeal teratomas with i(12p) analysis by FISH was recently reported by Gurda et al. 18 In that study, tumours with associated malignant GCT (yolk sac tumour) were excluded, but three of the paediatric cases had immature elements. Although recurrence was observed in three paediatric cases and four adult cases, no mortality was documented with a median follow-up of 6 years. Thirteen of these cases (nine paediatric and four adult) had FISH analysis performed, and none of the cases had an i(12p) abnormality. Our findings confirm the absence of i(12p) in both paediatric and adult sacrococcygeal teratoma cases, unless an associated malignant GCT component is present (Figure 3 ). Only one tumour with immature teratoma was analysed for i(12p) in the previous study, 18 and we have confirmed the absence of i(12p) in nine additional cases of teratoma with an immature component but no malignant germ cell component.
The i(12p) abnormality was not observed in the four adult sacrococcygeal teratomas. The i(12p) abnormality was detected in 8% (4/44) of paediatric sacrococcygeal GCTs, but only in those with a nonteratomatous component. This is similar to the findings in ovarian teratomas with and without a nonteratomatous component. These cytogenetic findings suggest that paediatric sacrococcygeal teratoma should be divided into two distinct groups, i.e. those with and those without other components, and that each group has a distinct molecular pathogenesis.
Ethics statement
The studies were performed according to the Declaration of Helsinki. The procedures were approved by a local ethics committee. Date of approval: 11 February 2015. Approval number: 1301010374. Full name: Indiana University Institutional Review Board. This was a retrospective study using pre-existing specimens, so informed written consent was not required by the Institutional Review Board. 
